Although moderate/strong expression of GM-CSF was detected in 44 out of the 87 (50.6%) cervical cancer tissues examined, this rate was markedly lower than that in the normal cervical tissues (81.3%) (Table 1 and Figure 2). This evidence concerns the gene CSF2 and cervical cancer.